L Pelosi1, E Mulroy2, R Leadbetter3, D Kilfoyle2, A M Chancellor1, S Mossman3, L Wing4, T Y Wu5, R H Roxburgh2,6. 1. Department of Neurology and Clinical Neurophysiology, Bay of Plenty District Health Board, Tauranga. 2. Auckland District Health Board, Auckland. 3. Capital and Coast District Health Board, Wellington. 4. Department of Endocrinology, Bay of Plenty District Health Board, Tauranga. 5. Christchurch Hospital, Christchurch. 6. Department of Medicine, University of Auckland, Auckland, New Zealand.
Abstract
BACKGROUND AND PURPOSE: Sensory neuronopathy is a cardinal feature of cerebellar ataxia neuropathy vestibular areflexia syndrome (CANVAS). Having observed that two patients with CANVAS had small median and ulnar nerves on ultrasound, we set out to examine this finding systematically in a cohort of patients with CANVAS, and compare them with both healthy controls and a cohort of patients with axonal neuropathy. We have previously reported preliminary findings in seven of these patients with CANVAS and seven healthy controls. METHODS: We compared the ultrasound cross-sectional area of median, ulnar, sural and tibial nerves of 14 patients with CANVAS with 14 healthy controls and 14 age- and gender-matched patients with acquired primarily axonal neuropathy. We also compared the individual nerve cross-sectional areas of patients with CANVAS and neuropathy with the reference values of our laboratory control population. RESULTS: The nerve cross-sectional area of patients with CANVAS was smaller than that of both the healthy controls and the neuropathy controls, with highly significant differences at most sites (P < 0.001). Conversely, the nerve cross-sectional areas in the upper limb were larger in neuropathy controls than healthy controls (P < 0.05). On individual analysis, the ultrasound abnormality was sufficiently characteristic to be detected in all but one patient with CANVAS. DISCUSSION: Small nerves in CANVAS probably reflect nerve thinning from loss of axons due to ganglion cell loss. This is distinct from the ultrasound findings in axonal neuropathy, in which nerve size was either normal or enlarged. Our findings indicate a diagnostic role for ultrasound in CANVAS sensory neuronopathy and in differentiating neuronopathy from neuropathy.
BACKGROUND AND PURPOSE:Sensory neuronopathy is a cardinal feature of cerebellar ataxia neuropathy vestibular areflexia syndrome (CANVAS). Having observed that two patients with CANVAS had small median and ulnar nerves on ultrasound, we set out to examine this finding systematically in a cohort of patients with CANVAS, and compare them with both healthy controls and a cohort of patients with axonal neuropathy. We have previously reported preliminary findings in seven of these patients with CANVAS and seven healthy controls. METHODS: We compared the ultrasound cross-sectional area of median, ulnar, sural and tibial nerves of 14 patients with CANVAS with 14 healthy controls and 14 age- and gender-matched patients with acquired primarily axonal neuropathy. We also compared the individual nerve cross-sectional areas of patients with CANVAS and neuropathy with the reference values of our laboratory control population. RESULTS: The nerve cross-sectional area of patients with CANVAS was smaller than that of both the healthy controls and the neuropathy controls, with highly significant differences at most sites (P < 0.001). Conversely, the nerve cross-sectional areas in the upper limb were larger in neuropathy controls than healthy controls (P < 0.05). On individual analysis, the ultrasound abnormality was sufficiently characteristic to be detected in all but one patient with CANVAS. DISCUSSION: Small nerves in CANVAS probably reflect nerve thinning from loss of axons due to ganglion cell loss. This is distinct from the ultrasound findings in axonal neuropathy, in which nerve size was either normal or enlarged. Our findings indicate a diagnostic role for ultrasound in CANVAS sensory neuronopathy and in differentiating neuronopathy from neuropathy.
Authors: Carolin K Scriba; Sarah J Beecroft; Joshua S Clayton; Andrea Cortese; Roisin Sullivan; Wai Yan Yau; Natalia Dominik; Miriam Rodrigues; Elizabeth Walker; Zoe Dyer; Teddy Y Wu; Mark R Davis; David C Chandler; Ben Weisburd; Henry Houlden; Mary M Reilly; Nigel G Laing; Phillipa J Lamont; Richard H Roxburgh; Gianina Ravenscroft Journal: Brain Date: 2020-10-01 Impact factor: 13.501
Authors: Marie Beaudin; Mario Manto; Jeremy D Schmahmann; Massimo Pandolfo; Nicolas Dupre Journal: Nat Rev Neurol Date: 2022-03-24 Impact factor: 42.937
Authors: Sarah J Beecroft; Andrea Cortese; Roisin Sullivan; Wai Yan Yau; Zoe Dyer; Teddy Y Wu; Eoin Mulroy; Luciana Pelosi; Miriam Rodrigues; Rachael Taylor; Stuart Mossman; Ruth Leadbetter; James Cleland; Tim Anderson; Gianina Ravenscroft; Nigel G Laing; Henry Houlden; Mary M Reilly; Richard H Roxburgh Journal: Brain Date: 2020-09-01 Impact factor: 13.501
Authors: Laurence Weinberg; Akshay Hungenahally; Joshua Meyerov; Lachlan Fraser Miles; Daniel Robert Anthony Cox; Vijayaragavan Muralidharan Journal: Int J Surg Case Rep Date: 2021-05-29
Authors: Andrea Cortese; Stefano Tozza; Wai Yan Yau; Salvatore Rossi; Sarah J Beecroft; Zane Jaunmuktane; Zoe Dyer; Gianina Ravenscroft; Phillipa J Lamont; Stuart Mossman; Andrew Chancellor; Thierry Maisonobe; Yann Pereon; Cecile Cauquil; Silvia Colnaghi; Giulia Mallucci; Riccardo Curro; Pedro J Tomaselli; Gilbert Thomas-Black; Roisin Sullivan; Stephanie Efthymiou; Alexander M Rossor; Matilde Laurá; Menelaos Pipis; Alejandro Horga; James Polke; Diego Kaski; Rita Horvath; Patrick F Chinnery; Wilson Marques; Cristina Tassorelli; Grazia Devigili; Lea Leonardis; Nick W Wood; Adolfo Bronstein; Paola Giunti; Stephan Züchner; Tanya Stojkovic; Nigel Laing; Richard H Roxburgh; Henry Houlden; Mary M Reilly Journal: Brain Date: 2020-02-01 Impact factor: 15.255